By targeting the hippocampus region of the brain, evenamide addresses schizophrenia at the source of dysfunction
1 Like
I’m sure that if Evenamide successfully completes phase 3, a pharmaceutical company will want to buy it, just like Bristol Myers acquired Cobenfy.
The drug is showing very promising results.
1 Like
I think you’re right.
1 Like